From April 1, 2023 to May 12, 2023, the company has repurchased 0 shares, representing 0% for ¥0 million. With this, the company has completed the repurchase of 263,900 shares, representing 0.6% for ¥545.29 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,039 JPY | +1.90% | -2.67% | +1.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.09% | 566M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.18% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.